Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy

Recruiting now · Phase 4

Conditions studied: Allergic Reactions

In brief

The study is to assess the safety of neffy or IM Adrenalin in patients who are experiencing allergic reactions after an OFC, allergen Immunotherapy (AIT), or other allergy challenge that may require epinephrine intervention.

Key facts

Study ID
NCT06834165
Run by
ARS Pharmaceuticals, Inc.
People needed
600
Starts
2025-05-20
Expected to finish
2027-06-01
Last updated by the study team
2026-04-21

Who can join

Age: 4 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.